|
|
Article: Instrumentation Metrics Preliminary Clinical Trial Data Suggests Success In Using Near-Infrared Spectroscopy to Non-Invasively Measure Blood Glucose Levels.
- Article from:
- PR Newswire
- Article date:
- February 21, 2001
CopyrightCOPYRIGHT 2001 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Interim Results From the Largest Study of Its Kind
Are Presented at Annual AIDPIT Meeting
CHANDLER, Ariz., Feb. 21 /PRNewswire/ --
Instrumentation Metrics, a Chandler, Arizona-based medical device company, recently presented interim data from a large scale (128 adult subjects), multi-center trial at the prestigious Artificial Insulin Delivery/Pancreas and Islet Transplantation (AIDPIT) meeting in Igls, Austria, held January 28-30, 2001. Instrumentation Metrics' preliminary results suggest that, over a large subject sample, the company's prototype noninvasive blood glucose monitor is the first device of its kind to accurately and precisely ...